Key result
Mitophagy dysregulation drives atherosclerotic progression, highlighting its essential role in maintaining cardiovascular health.
This review highlights the role of mitophagy in atherosclerotic disease and its potential as a cardioprotective target.
Mitochondrial health is essential for maintaining cardiac function, and mitophagy-the selective degradation of damaged mitochondria-is central to maintenance of mitochondrial quality. In this review, we focus on the role of mitophagy in atherosclerotic disease, exploring both canonical and noncanonical pathways. We aim to highlight how proper regulation of mitophagy supports cardiac health, while imbalances in this process can contribute to the onset and progression of cardiovascular conditions. In addition, we examine the cardioprotective potential of mitophagy in the context of disease and discuss its close relationship with mitochondrial dynamics, particularly as they relate to both macrovascular and microvascular dysfunction. Finally, we identify current gaps in knowledge and outline key questions that remain for the field to address, with the goal of guiding future research in this critical area of cardiovascular biology.
No takes yet. Share an insight, caveat, or question.
Wilcox et al. (2026) conducted a review in Atherosclerotic disease. Mitophagy was evaluated. Mitophagy plays a central role in maintaining mitochondrial quality and cardiac health, with its dysregulation contributing to the onset and progression of atherosclerotic cardiovascular conditions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: